Common TitleDOLCE
Official Title Dolutegravir-Lamivudine for naïve HIV-Infected Patients with ≤200 CD4/mm3
Phase Phase IV
ClinicalTrials.gov NCT04880395
Treatments
Dolutegravir-Lamivudine
Dolutegravir-Lamivudine
Tradename:DovatoOther Names:DTG-3TCClass:Single-Tablet RegimensFunding
IndustryViiV Healthcare